DRIO.NASDAQDariohealth CORP

SCHEDULE 13G/A: Nantahala Capital Management Discloses 9.99% Stake in DarioHealth Corp.

Sentiment:

Beneficial Ownership Report


Nantahala Capital Management, along with its principals Wilmot B. Harkey and Daniel Mack, reported a beneficial ownership of 9.99% in DarioHealth Corp. common stock as of December 31, 2024.

Summary

  • Nantahala Capital Management, LLC, an investment adviser, along with its managing members Wilmot B. Harkey and Daniel Mack, collectively reported beneficial ownership of 3,512,946 shares of DarioHealth Corp. common stock.
  • This ownership represents 9.99% of the total outstanding shares of DarioHealth Corp.
  • The reported ownership includes 1,068,267 shares that can be acquired within sixty days through the exercise of warrants.
  • The shares are held by funds and separately managed accounts under Nantahala's control.
  • The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as it reveals a significant, non-activist stake by a reputable investment firm, which can be seen as a vote of confidence. However, it's a factual ownership report, not a performance update, so the positive impact is limited to the signal of institutional interest.

Positives

  • A significant institutional investor, Nantahala Capital Management, maintains a substantial 9.99% stake in DarioHealth Corp., indicating continued confidence in the company.
  • The investment is stated to be for ordinary course of business, not for control, suggesting a passive investment strategy.

Future Outlook

NA

Industry Context

This filing indicates a significant investment by Nantahala Capital Management, an investment adviser, in DarioHealth Corp., a company likely operating in the healthcare or digital health sector given its name. Such a substantial stake by an institutional investor can signal market confidence in the company's long-term prospects within its industry.

Stakeholder Impact

  • Shareholders: Provides transparency regarding a significant institutional holding, potentially influencing investor sentiment and perception of the stock's stability or future prospects.

Key Dates

DateDescription
12/31/2024Date of event requiring the filing, representing the beneficial ownership stake as of this date.
02/14/2025Date the Schedule 13G Amendment No. 7 was filed with the SEC.

Keywords

DarioHealth Corp., Nantahala Capital Management, Wilmot B. Harkey, Daniel Mack, Beneficial Ownership, Schedule 13G, Common Stock, Investment Adviser, Institutional Investor, Shareholding, Warrants

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.